Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 94.39 M103.17 M90.27 M99.45 M 387.28 M Research & development ———— — Operating income 32.33 M74.92 M53.36 M35.36 M 195.97 M Non-Operating Income, Total -774 K-1.72 M-659 K-1.82 M -4.97 M Interest expense, net of interest capitalized 2.67 M2.37 M4.21 M6.48 M 15.73 M Non-Operating Income, excl. Interest Expenses -2.67 M-2.37 M-4.21 M-6.48 M -15.73 M Unusual income/expense -774 K-1.72 M-659 K-1.82 M -4.97 M Pretax income 28.89 M70.83 M48.49 M27.06 M 175.26 M Equity in earnings ———— — Taxes 5.28 M19.42 M2.34 M2.67 M 29.71 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 23.61 M51.41 M46.15 M24.39 M 145.55 M Discontinued operations ———— — Net income 23.61 M51.41 M46.15 M24.39 M 145.55 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 23.61 M51.41 M46.15 M24.39 M 145.55 M Basic earnings per share (Basic EPS) 0.410.890.790.42 2.51 Diluted earnings per share (Diluted EPS) 0.40.880.780.41 2.47 Average basic shares outstanding 58.1 M57.92 M58.37 M58.38 M — Diluted shares outstanding 59.01 M58.3 M59.13 M59.16 M — EBITDA 41.19 M83.79 M61.95 M41.16 M 228.09 M EBIT 31.31 M73.87 M52.01 M31.41 M 188.6 M Cost of revenue 204.31 M217.62 M220.89 M214.59 M 857.41 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 9.88 M9.92 M9.94 M9.75 M 39.48 M